Track topics on Twitter Track topics that are important to you
Johnson Matthey PLC Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.
Detailed information on Johnson Matthey PLC required for business and competitor intelligence needs
A study of the major internal and external factors affecting Johnson Matthey PLC in the form of a SWOT analysis
An indepth view of the business model of Johnson Matthey PLC including a breakdown and examination of key business segments
Intelligence on Johnson Matthey PLC's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Johnson Matthey PLC, such as business expansion, restructuring, and contract wins
Large number of easytograsp charts and graphs that present important data and key trends
Gain understanding of Johnson Matthey PLC and the factors that influence its strategies
Track strategic initiatives of the company and latest corporate news and actions
Assess Johnson Matthey PLC as a prospective partner, vendor or supplier
Support sales activities by understanding your customers' businesses better
Stay up to date on Johnson Matthey PLC's business structure, strategy and prospects
Johnson Matthey PLC JM or 'the group' is a global specialty chemicals business group. It operates primarily in Europe, North America and Asia. The group is headquartered in London, the UK, and employed 12,266 people as of March 31, 2015.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.